Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET Centre. The event offered a rich program—from tracer development to clinical applications in the nuclear medicine procedures, total‑body PET breakthroughs, and AI‑driven imaging strategies.
The dynamic exchange between seasoned experts, technologists, and early‑career researchers made it clear: innovation in nuclear medicine is accelerating.
Such forums go beyond technical curiosity: they are instrumental in shaping next‑generation diagnostics and refining trial design. Axcellant is energized by the practical insights gained and is already exploring how to integrate them into imaging‑based clinical research services.
We are committed to deepening our knowledge and strengthening our expertise in precision imaging, enabling us to continue delivering smarter, more effective trial solutions.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant